Characteristics | QFT + (n = 15) | QFT- (n = 65) | P |
---|---|---|---|
Mean age | 13.8(+/−3.5) | 12.1+/−4.5 | 0.16 |
Age < 5 | 0 | 6(9%) | 0.22 |
Females | 5(33.3%) | 38(57.5%) | 0.09 |
Mean BMI | 20.6+/−3.6 | 20.2+/−4.6 | 0.71 |
Born in TB endemic region | 10(66.7%) | 46(69.7%) | 0.82 |
Mother born in TB endemic region | 14(93.3%) | 56(84.9%) | 0.39 |
BCG vaccinated | 6(40%) | 20(30.3%) | 0.47 |
Mean CD4% | 31.4+/−11.3 | 32.1+/−9.3 | 0.79 |
CD4 > 25% | 10(66.7%) | 53(80.3%) | 0.51 |
CD4 15-25% | 4(26.7%) | 10(15.2%) | |
CD4 < 15% | 1(6.7%) | 3(4.6%) | |
Mean CD4 count | 744+/−331.5 | 846.7+/−483.8 | 0.44 |
Median CD4 count (IQR) | 769(481–1043) | 731(525–1012) | 0.88 |
Viral load log10 copies/ml | 3.6+/−1.3 | 3.5+/−0.86 | 0.87 |
Undetectable viral load | 10(66.7%) | 39(59.1%) | 0.59 |
No symptoms* | 5(33.3%) | 18(27.3%) | 0.91 |
Mild symptoms* | 5(33.3%0 | 23(34.8%) | |
Moderate symptoms* | 4(26.7%) | 17(25.8%) | |
Severe symptoms* | 1(6.7%) | 8(12.1%) | |
Proportion on ARV | 13(86.7%) | 55(83.3%) | 0.75 |
Median duration of ARV in years (IQR) | 7.33(2.2-10.84) | 8.04(1.84-11.8) | 0.91 |
3TC monotherapy | 0 | 4(6.1%) | 0.73 |
Combination ART | 13(86.7) | 51(77.3%) | 0.42 |